April 24, 2018
Sanofi’s leadership change in Research and Development
Sanofi’s Head of Global Research and Development, Elias Zerhouni, will retire from the company after more than 9 years, in the…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
April 24, 2018
FDA’s Arthritis Advisory Committee recommends approval of Eli Lilly’s, Incyte Corporation’s 2-mg dose of baricitinib
Eli Lilly and Incyte Corporation scored a recommended approval of the 2-mg dose of a once-daily oral medication baricitinib from…
April 23, 2018
Beximco brings competition to Auxilium’s muscle relaxant Robaxin in USA
Beximco Pharmaceuticals has begin the export Methocarbamol tablets to the US, generic equivalent to Auxilium Pharmaceuticals’ muscle relaxant Robaxin tablets, 500mg…
April 20, 2018
Hikma’s USA subsidiary launches Zinecard generic, Dexrazoxane, for breast cancer
Hikma Pharmaceuticals has launched Dexrazoxane for Injection, 250mg and 500mg vials, the generic equivalent to Zinecard, through its US wholly-owned subsidiary…
April 20, 2018
Boehringer Ingelheim and HealthPrize Technologies expand RespiPoints digital support program
Boehringer Ingelheim and HealthPrize Technologies are expanding the RespiPoints digital support program to anyone taking one of several Boehringer Ingelheim…
April 18, 2018
Ultragenyx Pharmaceutical’s Crysvita first FDA-approved medication for the treatment of XLH
The U.S. Food and Drug Administration has approved Ultragenyx Pharmaceutical’s Crysvita (burosumab), the first drug approved to treat adults and children ages…
April 18, 2018
Creso’s JV in launching of Global Beers and Tonics
Creso Pharma said Wednesday that CLV Frontier Brands Pty, its equal one-third joint venture with UK-based Baltic Beer Company and…
April 17, 2018
Sanofi sells Zentiva for €1.9 billion
Sanofi has gotten an offer from Advent International, a global investor in healthcare sector, for purchase of Zentiva, Sanofi’s European…
April 16, 2018
Investigational gene therapy product Lymfactin for the treatment of secondary lymphedema tested in phase 1 study
Herantis Pharma has gotten positive results from a safety evaluation in the ongoing Phase 1 clinical study of its investigational…
April 16, 2018
Telix Pharmaceuticals’s collaboration with INSERM and ARRONAX can deliver products for greater clinical utility to cancer patients
Telix Pharmaceuticals, the specialist for radiopharmaceuticals or “molecularly-targeted radiation” (MTR), has entered into a research partnership with the French National…